Hitachi Medical Systems America, Inc.: FDA filings under this applicant name
FDA lists 100 510(k) clearances under the applicant name “Hitachi Medical Systems America, Inc.” (first 1991, latest 2017), across 13 product codes in 2 review panels. Median 510(k) review time under this name: 78 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Fujifilm Healthcare, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 2 | 180 |
| 2013 | 1 | 136 |
| 2014 | 0 | — |
| 2015 | 5 | 160 |
| 2016 | 4 | 82 |
| 2017 | 1 | 77 |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Hitachi Medical Systems America, Inc. took a median 77 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 112 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LNH | System, Nuclear Magnetic Resonance Imaging | 54 | 54 |
| MOS | Coil, Magnetic Resonance, Specialty | 18 | 18 |
| JAK | System, X-Ray, Tomography, Computed | 12 | 12 |
| IYN | System, Imaging, Pulsed Doppler, Ultrasonic | 5 | 5 |
| IYO | System, Imaging, Pulsed Echo, Ultrasonic | 2 | 2 |
| LNI | System, Nuclear Magnetic Resonance Spectroscopic | 2 | 2 |
| DQA | Oximeter | 1 | 1 |
| IZI | System, X-Ray, Angiographic | 1 | 1 |
| IZL | System, X-Ray, Mobile | 1 | 1 |
| JAA | System, X-Ray, Fluoroscopic, Image-Intensified | 1 | 1 |
Plus 3 more product codes.
Review panels
- Radiology (99)
- Anesthesiology (1)
Most recent Hitachi Medical Systems America, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K163528 | HITACHI Supria Whole-body X-ray CT System Phase 3 | JAK | 2017-03-03 | 77 |
| K162079 | TRILLIUM Oval Head Coil 32 | MOS | 2016-09-16 | 51 |
| K161748 | SUPRIA w/guideShot Option | JAK | 2016-08-17 | 54 |
| K160152 | Trillium Oval V 5.1 MRI System | LNH | 2016-05-20 | 119 |
| K153547 | ECHELON Oval V 5.1 MRI System | LNH | 2016-03-31 | 111 |
| K150595 | SCENARIA Phase 3 Whole-body X-ray CT System | JAK | 2015-10-30 | 235 |
| K150565 | Supria Whole-body X-ray CT System | JAK | 2015-09-30 | 208 |
| K151015 | ECHELON Oval V 5.0 MRI System | LNH | 2015-07-29 | 104 |
| K143537 | Sirius Starmobile tiara | IZL | 2015-03-06 | 81 |
| K142734 | TRILLIUM Oval MR System | LNH | 2015-03-02 | 160 |
90 earlier clearances. See the full list in Caduvo.
Recalls
45 product recalls in 38 recall events; 0 initiated in the last five years. Most recent: 2021-03-01.
1 product recall in 1 recall event filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Hitachi Healthcare Americas Corporation (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Hitachi Medical Systems America, Inc. (a text match, not an official crosswalk):
- C8903 — Magnetic resonance imaging with contrast, breast; unilateral (via LNH)
- C8906 — Magnetic resonance imaging with contrast, breast; bilateral (via LNH)
- C8905 — Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral (via LNH)
- C8908 — Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral (via LNH)
- C8900 — Magnetic resonance angiography with contrast, abdomen (via LNI)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Hitachi Medical Corp. of America (32 510(k)s)
- Hitachi Healthcare Americas (17 510(k)s)
- Hitachi Chemical Diagnostics, Inc. (16 510(k)s)
- Hitachi Medical Corp. (12 510(k)s)
- Hitachi , Ltd. (8 510(k)s)
- Hitachi Aloka Medical, Ltd. (6 510(k)s)
- Hitachi, Ltd., Health Care Company (4 510(k)s)
- Hitachi Aloka Medical America, Inc. (3 510(k)s)
- Hitachi Aloka Medical,Ltd. (Hitachi Aloka Medical (3 510(k)s)
- Hitachi, Ltd., Power Systems Group (2 510(k)s)
- Hitachi, Ltd. Radiation Oncology Systems, Kashiwanoha (2 510(k)s)
- Hitachi Sales Corporation of America (2 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Hitachi Medical Systems America, Inc.?
FDA lists 100 510(k) clearances under the applicant name “Hitachi Medical Systems America, Inc.” (first 1991, latest 2017), across 13 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Hitachi Medical Systems America, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Hitachi Medical Systems America, Inc. is 78 days.
Which FDA product codes appear under Hitachi Medical Systems America, Inc.?
The most frequent FDA product codes under this applicant name are LNH (System, Nuclear Magnetic Resonance Imaging, 54); MOS (Coil, Magnetic Resonance, Specialty, 18); JAK (System, X-Ray, Tomography, Computed, 12).
Next steps
- See all 100 Hitachi Medical Systems America, Inc. clearances with predicates and recalls
- Run predicate analysis for product code LNH, Hitachi Medical Systems America, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.